Another study showed that a CEA of >30 ng/mL—as measured in the pancreatic exocrine product—was an independent factor associated with malignancy in BD-IPMN with a PPV of 100% and a NPV of 96.3% [23]. This evidence concerns the gene CEACAM5 and pancreatic intraductal papillary-mucinous neoplasm.